DRUGS MADE IN AMERICA ACQUIS (DMAA) Stock Price, Quote, News and Overview

What is the stock price of DRUGS MADE IN AMERICA ACQUIS today?

The current stock price of DMAA is 10.11 USD.

What is the ticker symbol for DRUGS MADE IN AMERICA ACQUIS stock?

The exchange symbol of DRUGS MADE IN AMERICA ACQUIS is DMAA and it is listed on the Nasdaq exchange.

On which exchange is DMAA stock listed?

DMAA stock is listed on the Nasdaq exchange.

What is DRUGS MADE IN AMERICA ACQUIS worth?

DRUGS MADE IN AMERICA ACQUIS (DMAA) has a market capitalization of 338.89M USD. This makes DMAA a Small Cap stock.

How many employees does DRUGS MADE IN AMERICA ACQUIS have?

DRUGS MADE IN AMERICA ACQUIS (DMAA) currently has 0 employees.

What are the support and resistance levels for DRUGS MADE IN AMERICA ACQUIS (DMAA) stock?

DRUGS MADE IN AMERICA ACQUIS (DMAA) has a support level at 10.1 and a resistance level at 10.12. Check the full technical report for a detailed analysis of DMAA support and resistance levels.

Should I buy DRUGS MADE IN AMERICA ACQUIS (DMAA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of DMAA, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of DMAA, evaluating the profitability, health, valuation and growth aspects
• DRUGS MADE IN AMERICA ACQUIS (DMAA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• DRUGS MADE IN AMERICA ACQUIS (DMAA) Sales and EPS estimates to see what analysts future expectations are.
• DRUGS MADE IN AMERICA ACQUIS (DMAA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• DRUGS MADE IN AMERICA ACQUIS (DMAA) Insider and Institutional Ownership to learn about the owners and their transactions.
• DRUGS MADE IN AMERICA ACQUIS (DMAA) Stock Chart to make your own analysis
• DRUGS MADE IN AMERICA ACQUIS (DMAA) Latest news and press-releases to stay up to date.

Does DRUGS MADE IN AMERICA ACQUIS (DMAA) stock pay dividends?

DMAA does not pay a dividend.

What is the Price/Earnings (PE) ratio of DRUGS MADE IN AMERICA ACQUIS (DMAA)?

DRUGS MADE IN AMERICA ACQUIS (DMAA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.01).

What is the Short Interest ratio of DRUGS MADE IN AMERICA ACQUIS (DMAA) stock?

The outstanding short interest for DRUGS MADE IN AMERICA ACQUIS (DMAA) is 0.1% of its float. Check the ownership tab for more information on the DMAA short interest.

Over the last trailing twelve months DMAA reported a non-GAAP Earnings per Share(EPS) of -0.01.